Compartilhar
Informação da revista
Vol. 31. Núm. 7.
Páginas 541.e1-541.e53 (Julho - Agosto 2012)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 31. Núm. 7.
Páginas 541.e1-541.e53 (Julho - Agosto 2012)
Recomendações
DOI: 10.1016/j.repc.2012.05.007
Open Access
Recomendações da ESC para o tratamento da cardiopatia congénita no adulto (nova versão de 2010)
Visitas
9568
Apoiadas pela Association for European Paediatric Cardiology (Associaçao Europeia de Cardiologia Pediátrica) (AEPC)
Autores / Membros do Grupo de Trabalho: Helmut Baumgartner (Presidente) (Alemanha)
, Philipp Bonhoeffer (Reino Unido), Natasja M. S. De Groot (Holanda), Fokko de Haan (Alemanha), John Erik Deanfield (Reino Unido), Nazzareno Galie (Itália), Michael A. Gatzoulis (Reino Unido), Christa Gohlke-Baerwolf (Alemanha), Harald Kaemmerer (Alemanha), Philip Kilner (Reino Unido), Folkert Meijboom (Holanda), Barbara J. M.Mulder (Holanda), Erwin Oechslin (Canadá), Jose M. Oliver (Espanha), Alain Serraf (França), Andras Szatmari (Hungria), Erik Thaulow (Noruega), Pascal R. Vouhe (França), Edmond Walma (Holanda)
Comissão da ESC para as Recomendações Práticas (CRP): Alec Vahanian (Presidente) (França), Angelo Auricchio (Suíça), Jeroen Bax (Holanda), Claudio Ceconi (Itália), Veronica Dean (França), Gerasimos Filippatos (Grécia), Christian Funck-Brentano (França), Richard Hobbs (Reino Unido), Peter Kearney (Irlanda), Theresa McDonagh (Reino Unido), Bogdan A. Popescu (Roménia), Zeljko Reiner (Croácia), Udo Sechtem (Alemanha), Per Anton Sirnes (Noruega), Michal Tendera (Polónia), Panos Vardas (Grécia), Petr Widimsky (República Checa)
Revisores do Documento: Theresa McDonagh (Coordenador da Revisão das CRP) (Reino Unido), LornaSwan (CO - coordenador da Revisão) (Reino Unido), Felicita Andreotti (Itália), Maurice Beghetti (Suíça), Martin Borggrefe (Alemanha), Andre Bozio (França), Stephen Brecker (Reino Unido), Werner Budts (Bélgica), John Hess (Alemanha), Rafael Hirsch (Israel), Guillaume Jondeau (França), Jorma Kokkonen (Finlândia), Mirta Kozelj (Eslovénia), Serdar Kucukoglu (Turquia), Mari Laan (Estónia), Christos Lionis (Grécia), Irakli Metreveli (Geórgia), Philip Moons (Bélgica), Petronella G. Piepee (Holanda), Vladimir Pilossoff (Bulgária), Jana Popelova (República Checa), Susanna Price (Reino Unido), Jolien Roos-Hesselink (Holanda), Miguel Sousa Uva (Portugal), Pilar Tornos (Espanha), Pedro Trigo Trindade (Suíça), Heikki Ukkonen (Finlândia), HamishWalker (Reino Unido), Gary D.Webb (EUA), Jorgen Westby (Noruega)
A filiação dos autores e revisores pode ser encontrada na página dedicada a estas recomendações no sftio da Internet da ESC www.escardio.org/guidelines. Entidades da ESC que participaram na elaboração deste documento:Associates: European Association of Percutaneous Cardiovascular Interventions (Associação Europeia de Intervenções Cardiovasculares Percutâneas) (EAPCI), European Heart Rhythm Association (Associação Europeia do Ritmo Cardíaco) (EHRA), Heart Failure Association (Associação de Insuficiência Cardíaca) (HFA), European Association of Echocardiography (Associação Europeia de Ecocardiografia) (EAE)Conselhos: Cardiology Practice (Cardiologia Clfnica), Council on Primary Care (Conselho para os Cuidados Primários), Cardiovascular Imaging (Imagiologia Cardiovascular), Cardiovascular Nursing and Allied Professions (Enfermagem Cardiovascular e Profissões Associadas) (CCNAP)) Grupos de Trabalho: Cardiopatia Congénita no Adulto, Circulação Pulmonar e Função Ventricular Direita, Doença Valvular Cardíaca, Cirurgia Cardiovascular, Trombose, Cuidados Intensivos Cardíacos
Este item recebeu
9568
Visitas

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Texto Completo
Referências
[1]
C.A. Warnes, R. Liberthson, G.K. Danielson, A. Dore, L. Harris, J.I. Hoffman, J. Somerville, R.G. Williams, G.D. Webb.
Task force 1: the changing profile of congenital heart disease in adult life.
J Am Coll Cardiol, 37 (2001), pp. 1170-1175
[2]
J. Deanfield, E. Thaulow, C. Warnes, G. Webb, F. Kolbel, A. Hoffman, K. Sorenson, H. Kaemmer, U. Thilen, M. Bink-Boelkens, L. Iserin, L. Daliento, E. Silove, A. Redington, P. Vouhe, S. Priori, M.A. Alonso, J.J. Blanc, A. Budaj, M. Cowie, J. Deckers, E. Fernandez Burgos, J. Lekakis, B. Lindahl, G. Mazzotta, J. Morais, A. Oto, Smiseth 0, H.J. Trappe, W. Klein, C. Blomstrom-Lundqvist, G. de Backer, J. Hradec, G. Mazzotta, A. Parkhomenko, P. Presbitero, A. Torbicki.
Management of grown up congenital heart disease.
Eur Heart J, 24 (2003), pp. 1035-1084
[3]
P.J. Kilner, T. Geva, H. Kaemmerer, P.T. Trindade, J. Schwitter, G.D. Webb.
Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology.
Eur Heart J, 31 (2010), pp. 794-805
[4]
G.P. Diller, K. Dimopoulos, D. Okonko, W. Li, S.V. Babu-Narayan, C.S. Broberg, B. Johansson, B. Bouzas, M.J. Mullen, P.A. Poole-Wilson, D.P. Francis, M.A. Gatzoulis.
Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
Circulation, 112 (2005), pp. 828-835
[5]
N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, J.A. Barbera, M. Beghetti, P. Corris, S. Gaine, J.S. Gibbs, M.A. Gomez-Sanchez, G. Jondeau, W. Klepetko, C. Opitz, A. Peacock, L. Rubin, M. Zellweger, G. Simonneau.
Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Respir J, 34 (2009), pp. 1219-1263
[6]
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442.
[7]
J. Somerville.
Management of adults with congenital heart disease: an increasing problem.
Annu Rev Med, 48 (1997), pp. 283-293
[8]
Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000; 86:llll-1116.
[9]
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman. B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy. C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006;27:2099-2140.
[10]
Garson A Jr, McNamara DG. Sudden death in a pediatric cardiology population, 1958 to 1983: relation to prior arrhythmias. J Am Coll Cardiol 1985; 5:134B-137B.
[11]
T.P. Graham Jr., D.J. Driscoll, W.M. Gersony, J.W. Newburger, A. Rocchini, J.A. Towbin.
Task Force 2: congenital heart disease.
J Am Coll Cardiol, 45 (2005), pp. 1326-1333
[12]
R.O. Bonow, M.D. Cheitlin, M.H. Crawford, P.S. Douglas.
Task Force 3: valvular heart disease.
J Am Coll Cardiol, 45 (2005), pp. 1334-1340
[13]
A. Pelliccia, R. Fagard, H.H. Bjornstad, A. Anastassakis, E. Arbustini, D. Assanelli, A. Biffi, M. Borjesson, F. Carre, D. Corrado, P. Delise, U. Dorwarth, A. Hirth, H. Heidbuchel, E. Hoffmann, K.P. Mellwig, N. Panhuyzen-Goedkoop, A. Pisani, E.E. Solberg, F. van-Buuren, L. Vanhees, C. Blomstrom-Lundqvist, A. Deligiannis, D. Dugmore, M. Glikson, P.I. Hoff, A. Hoffmann, E. Hoffmann, D. Horstkotte, J.E. Nordrehaug, J. Oudhof, W.J. McKenna, M. Penco, S. Priori, T. Reybrouck, J. Senden, A. Spataro, G. Thiene.
Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and theWorking Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
Eur Heart J, 26 (2005), pp. 1422-1445
[14]
W.S. Avila, M. Grinberg, R. Snitcowsky, R. Faccioli, P.L. da Luz, G. Bellotti, F. Pileggi.
Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome.
Eur Heart J, 16 (1995), pp. 460-464
[15]
P. Presbitero, J. Somerville, S. Stone, E. Aruta, D. Spiegelhalter, F. Rabajoli.
Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus.
Circulation, 89 (1994), pp. 2673-2676
[16]
S.C. Siu, M. Sermer, J.M. Colman, A.N. Alvarez, L.A. Mercier, B.C. Morton, C.M. Kells, M.L. Bergin, M.C. Kiess, F. Marcotte, D.A. Taylor, E.P. Gordon, J.C. Spears, J.W. Tarn, K.S. Amankwah, J.F. Smallhorn, D. Farine, S. Sorensen.
Prospective multicenter study of pregnancy outcomes in women with heart disease.
Circulation, 104 (2001), pp. 515-521
[17]
J.J. Nora, A.H. Nora.
Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens.
Am J Cardiol, 59 (1987), pp. 459-463
[18]
M.A. Gatzoulis, M.A. Freeman, S.C. Siu, G.D. Webb, L. Harris.
Atrial arrhythmia after surgical closure of atrial septal defects in adults.
N Engl J Med, 340 (1999), pp. 839-846
[19]
J.G. Murphy, B.J. Gersh, M.D. McGoon, D.D. Mair, C.J. Porter, D.M. Ilstrup, D.C. McGoon, F.J. Puga, J.W. Kirklin, G.K. Danielson.
Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years.
N Engl J Med, 323 (1990), pp. 1645-1650
[20]
J.W. Roos-Hesselink, F.J. Meijboom, S.E. Spitaels, D.R. van, E.H. van Rijen, E.M. Utens, A.J. Bogers, M.L. Simoons.
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years.
Eur Heart J, 24 (2003), pp. 190-197
[21]
G. Butera, M. Carminati, M. Chessa, R. Youssef, M. Drago, A. Giamberti, G. Pome’, E. Bossone, A. Frigiola.
Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications.
Am Heart J, 151 (2006), pp. 228-234
[22]
G. Fischer, J. Stieh, A. Uebing, U. Hoffmann, G. Morf, H.H. Kramer.
Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients.
Heart, 89 (2003), pp. 199-204
[23]
Z. Amin, Z.M. Hijazi, J.L. Bass, J.P. Cheatham, W.E. Hellenbrand, C.S. Kleinman.
Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk.
Catheter Cardiovasc Interv, 63 (2004), pp. 496-502
[24]
Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004; 43:302-309.
[25]
Z.D. Du, Z.M. Hijazi, C.S. Kleinman, N.H. Silverman, K. Larntz.
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial.
J Am Coll Cardiol, 39 (2002), pp. 1836-1844
[26]
F. Attie, M. Rosas, N. Granados, C. Zabal, A. Buendia, J. Calderon.
Surgical treatment for secundum atrial septal defects in patients.40 years old. A randomized clinical trial.
J Am Coll Cardiol, 38 (2001), pp. 2035-2042
[27]
Humenberger M, Rosenhek R, Gabriel H, Rader F, Heger M, Klaar U, Binder Th, Probst P, Heinze G, Maurer G, Baumgartner H. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J 2010 (in press).
[28]
J.P. Jacobs, R.P. Burke, J.A. Quintessenza, C. Mavroudis.
Congenital Heart Surgery Nomenclature and Database Project: ventricular septal defect.
Ann Thorac Surg, 69 (2000), pp. S25-S35
[29]
T. Miyake, T. Shinohara, T. Fukuda, M. Ikeoka, T. Takemura.
Spontaneous closure of perimembranous ventricular septal defect after school age.
Pediatr Int, 50 (2008), pp. 632-635
[30]
H.M. Gabriel, M. Heger, P. Innerhofer, M. Zehetgruber, G. Mundigler, M. Wimmer, G. Maurer, H. Baumgartner.
Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood.
J Am Coll Cardiol, 39 (2002), pp. 1066-1071
[31]
U. Neumayer, S. Stone, J. Somerville.
Small ventricular septal defects in adults.
Eur Heart J, 19 (1998), pp. 1573-1582
[32]
V. Soufflet, B.A. Van de, E. Troost, M. Gewillig, P. Moons, M.C. Post, W. Budts.
Behavior of unrepaired perimembranous ventricular septal defect in young adults.
Am J Cardiol, 105 (2010), pp. 404-407
[33]
F. Meijboom, A. Szatmari, E. Utens, J.W. Deckers, J.R. Roelandt, E. Bos, J. Hess.
Longterm follow-up after surgical closure of ventricular septal defect in infancy and childhood.
J Am Coll Cardiol, 24 (1994), pp. 1358-1364
[34]
L. Kidd, D.J. Driscoll, W.M. Gersony, C.J. Hayes, J.F. Keane, W.M. O’Fallon, D.R. Pieroni, R.R. Wolfe, W.H. Weidman.
Second natural history study of congenital heart defects, Results of treatment of patients with ventricular septal defects.
Circulation, 87 (1993), pp. I38-I51
[35]
A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. lung, J. Kasprzak, P. Nataf, P. Tornos, L. Torracca, A. Wenink.
Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.
Eur Heart J, 28 (2007), pp. 230-268
[36]
M.A. Gatzoulis, S. Hechter, G.D. Webb, W.G. Williams.
Surgery for partial atrioventricular septal defect in the adult.
Ann Thorac Surg, 67 (1999), pp. 504-510
[37]
E.K. El-Najdawi, D.J. Driscoll, F.J. Puga, J.A. Dearani, B.E. Spotts, D.W. Mahoney, G.K. Danielson.
Operation for partial atrioventricular septal defect: a forty-year review.
J Thorac Cardiovasc Surg, 119 (2000), pp. 880-889
[38]
S.P. Malhotra, F. Lacour-Gayet, M.B. Mitchell, D.R. Clarke, M.L. Dines, D.N. Campbell.
Reoperation for left atrioventricular valve regurgitation after atrioventricular septal defect repair.
Ann Thorac Surg, 86 (2008), pp. 147-151
[39]
W. Drenthen, P.G. Pieper, T.K. van der, J.W. Roos-Hesselink, A.A. Voors, B. Mostert, B.J. Mulder, P. Moons, T. Ebels, D.J. van Veldhuisen.
Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects.
Eur Heart J, 26 (2005), pp. 2581-2587
[40]
J. Burn, P. Brennan, J. Little, S. Holloway, R. Coffey, J. Somerville, N.R. Dennis, L. Allan, R. Arnold, J.E. Deanfield, M. Godman, A. Houston, B. Keeton, C. Oakley, O. Scott, E. Silove, J. Wilkinson, M. Pembrey, A.S. Hunter.
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study.
Lancet, 351 (1998), pp. 311-316
[41]
Fisher RG, Moodie DS, Sterba R, Gill CC. Patent ductus arteriosus in adults— long-term follow-up: nonsurgical versus surgical treatment. J Am Coll Cardiol 1986;8:280-284.
[42]
Harrison DA, Benson LN, Lazzam C, Walters JE, Siu S, McLaughlin PR. Percutaneous catheter closure of the persistently patent ductus arteriosus in the adult. Am J Cardiol 1996; 77:1094-1097.
[43]
S. John, S. Muralidharan, P.S. Jairaj, G.K. Mani, Babuthaman, S. Krishnaswamy, I.P. Sukumar, G. Cherian.
The adult ductus: review of surgical experience with 131 patients.
J Thorac Cardiovasc Surg, 82 (1981), pp. 314-319
[44]
R. Rosenhek, T. Binder, G. Porenta, I. Lang, G. Christ, M. Schemper, G. Maurer, H. Baumgartner.
Predictors of outcome in severe, asymptomatic aortic stenosis.
N Engl J Med, 343 (2000), pp. 611-617
[45]
N. Tzemos, J. Therrien, J. Yip, G. Thanassoulis, S. Tremblay, M.T. Jamorski, G.D. Webb, S.C. Siu.
Outcomes in adults with bicuspid aortic valves.
JAMA, 300 (2008), pp. 1317-1325
[46]
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, lung B, Otto CM, Pellikka PA, Quin∼ones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. EurJ Echocardiogr 2009; 10:l-25.
[47]
A.B. Rossebo, T.R. Pedersen, K. Boman, P. Brudi, J.B. Chambers, K. Egstrup, E. Gerdts, C. Gohlke-Barwolf, I. Holme, Y.A. Kesaniemi, W. Malbecq, C.A. Nienaber, S. Ray, T. Skjaerpe, K. Wachtell, R. Willenheimer.
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
N Engl J Med, 359 (2008), pp. 1343-1356
[48]
J.J. Takkenberg, L.M. Klieverik, P.H. Schoof, R.J. van Suylen, L.A. van Herwerden, P.E. Zondervan, J.W. Roos-Hesselink, M.J. Eijkemans, M.H. Yacoub, A.J. Bogers.
The Ross procedure: a systematic review and meta-analysis.
Circulation, 119 (2009), pp. 222-228
[49]
Z. Urban, J. Zhang, E.C. Davis, G.K. Maeda, A. Kumar, H. Stalker, J.W. Belmont, C.D. Boyd, M.R. Wallace.
Supravalvular aortic stenosis: genetic and molecular dissection of a complex mutation in the elastin gene.
Hum Genet, 109 (2001), pp. 512-520
[50]
T.M. Burch, F.X. McGowan Jr., B.D. Kussman, A.J. Powell, J.A. DiNardo.
Congenital supravalvular aortic stenosis and sudden death associated with anesthesia: what's the mystery.
Anesth Analg, 107 (2008), pp. 1848-1854
[51]
E.J. Hickey, G. Jung, W.G. Williams, C. Manlhiot, G.S. Van Arsdell, C.A. Caldarone, J. Coles, B.W. McCrindle.
Congenital supravalvular aortic stenosis: defining surgical and nonsurgical outcomes.
Ann Thorac Surg, 86 (2008), pp. 1919-1927
[52]
J.M. Oliver, A. Gonzalez, P. Gallego, A. Sanchez-Recalde, F. Benito, J.M. Mesa.
Discrete subaortic stenosis in adults: increased prevalence and slow rate of progression of the obstruction and aortic regurgitation.
J Am Coll Cardiol, 38 (2001), pp. 835-842
[53]
K. Niwa, J.K. Perloff, S.M. Bhuta, H. Laks, D.C. Drinkwater, J.S. Child, P.D. Miner.
Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses.
Circulation, 103 (2001), pp. 393-400
[54]
M. Campbell.
Natural history of coarctation of the aorta.
Br Heart J, 32 (1970), pp. 633-640
[55]
M. Cohen, V. Fuster, P.M. Steele, D. Driscoll, D.C. McGoon.
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction.
Circulation, 80 (1989), pp. 840-845
[56]
L. Shah, Z. Hijazi, S. Sandhu, A. Joseph, Q.L. Cao.
Use of endovascular stents for the treatment of coarctation of the aorta in children and adults: immediate and midterm results.
J Invasive Cardiol, 17 (2005), pp. 614-618
[57]
Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg 2007;134:738-745.
[58]
H.M. Connolly, J. Huston III, R.D. Brown Jr., C.A. Warnes, N.M. Ammash, A.J. Tajik.
Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients.
Mayo Clin Proc, 78 (2003), pp. 1491-1499
[59]
L.M. Beauchesne, H.M. Connolly, N.M. Ammash, C.A. Warnes.
Coarctation of the aorta: outcome of pregnancy.
J Am Coll Cardiol, 38 (2001), pp. 1728-1733
[60]
A. De Paepe, R.B. Devereux, H.C. Dietz, R.C. Hennekam, R.E. Pyeritz.
Revised diagnostic criteria for the Marfan syndrome.
[61]
B.L. Loeys, H.C. Dietz, A.C. Braverman, B.L. Callewaert, J. De Backer, R.B. Devereux, Y. Hillhorst-Hofstee, G. Jondeau, L. Faivre, D.M. Millewicz, R.E. Pyeritz, P.D. Sponseller, P. Wordsworth, A.M. De Paepe.
The revised Ghent nosology for the Marfan syndrome.
J Med Genet, 47 (2010), pp. 476-485
[62]
G.J. Nollen, M. Groenink, J.G. Tijssen, E.E. van der Wall, B.J. Mulder.
Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome.
Eur Heart J, 25 (2004), pp. 1146-1152
[63]
P. Engelfriet, B. Mulder.
Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome?.
Int J Cardiol, 114 (2007), pp. 300-302
[64]
J. Shores, K.R. Berger, E.A. Murphy, R.E. Pyeritz.
Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.
N Engl J Med, 330 (1994), pp. 1335-1341
[65]
V.L. Gott, P.S. Greene, D.E. Alejo, D.E. Cameron, D.C. Naftel, D.C. Miller, A.M. Gillinov, J.C. Laschinger, R.E. Pyeritz.
Replacement of the aortic root in patients with Marfan's syndrome.
N Engl J Med, 340 (1999), pp. 1307-1313
[66]
K. Kallenbach, H. Baraki, N. Khaladj, H. Kamiya, C. Hagl, A. Haverich, M. Karck.
Aortic valve-sparing operation in Marfan syndrome: what do we know after a decade?.
Ann Thorac Surg, 83 (2007), pp. S764-S768
[67]
M. Groenink, T.A. Lohuis, J.G. Tijssen, M.S. Naeff, R.C. Hennekam, E.E. van der Wall, B.J. Mulder.
Survival and complication free survival in Marfan's syndrome: implications of current guidelines.
Heart, 82 (1999), pp. 499-504
[68]
U. Meijboom, J. Timmermans, A.H. Zwinderman, P.M. Engelfriet, B.J. Mulder.
Aortic root growth in men and women with the Marfan's syndrome.
Am J Cardiol, 96 (2005), pp. 1441-1444
[69]
R.R. Davies, A. Gallo, M.A. Coady, G. Tellides, D.M. Botta, B. Burke, M.P. Coe, G.S. Kopf, J.A. Elefteriades.
Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms.
Ann Thorac Surg, 81 (2006), pp. 169-177
[70]
L.G. Svensson, N.T. Kouchoukos, D.C. Miller, J.E. Bavaria, J.S. Coselli, M.A. Curi, H. Eggebrecht, J.A. Elefteriades, R. Erbel, T.G. Gleason, B.W. Lytle, R.S. Mitchell, C.A. Nienaber, E.E. Roselli, H.J. Safi, R.J. Shemin, G.A. Sicard, T.M. Sundt 3rd, W.Y. Szeto, Wheatley GH.
3rd. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts.
Ann Thorac Surg, 85 (2008), pp. S1-S41
[71]
L.J. Meijboom, F.E. Vos, J. Timmermans, G.H. Boers, A.H. Zwinderman, B.J. Mulder.
Pregnancy and aortic root growth in the Marfan syndrome: a prospective study.
Eur Heart J, 26 (2005), pp. 914-920
[72]
McElhinney DB, Goldmuntz E. Double-chambered right ventricle. In: Gatzoulis MA, Webb GD, Daubeney PE, eds. Diagnosis and management of adult congenital heart disease. London: Churchill Livingstone; 2003. p 305-311.
[73]
J.M. Oliver, A. Garrido, A. Gonzalez, F. Benito, M. Mateos, A. Aroca, E. Sanz.
Rapid progression of midventricular obstruction in adults with double-chambered right ventricle.
J Thorac Cardiovasc Surg, 126 (2003), pp. 711-717
[74]
C.J. Hayes, W.M. Gersony, D.J. Driscoll, J.F. Keane, L. Kidd, W.M. O’Fallon, D.R. Pieroni, R.R. Wolfe, W.H. Weidman.
Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis.
Circulation, 87 (1993), pp. I28-I37
[75]
M. Jarrar, F. Betbout, M.B. Farhat, F. Maatouk, H. Gamra, F. Addad, S. Hammami, K.B. Hamda.
Long-term invasive and noninvasive results of percutaneous balloon pulmonary valvuloplasty in children, adolescents, and adults.
Am Heart J, 138 (1999), pp. 950-954
[76]
G.R. Veldtman, J.A. Dearani, C.A. Warnes.
Low pressure giant pulmonary artery aneurysms in the adult: natural history and management strategies.
Heart, 89 (2003), pp. 1067-1070
[77]
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ,Walsh EP,Webb GD. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008;118:e714-e833.
[78]
S. Chauvaud, A. Berrebi, N. d’Attellis, E. Mousseaux, A. Hernigou, A. Carpentier.
Ebstein's anomaly: repair based on functional analysis.
Eur J Cardiothorac Surg, 23 (2003), pp. 525-531
[79]
S.K. Furer, J.A. Gomes, B. Love, D. Mehta.
Mechanism and therapy of cardiac arrhythmias in adults with congenital heart disease.
Mt Sinai J Med, 72 (2005), pp. 263-269
[80]
J.A. Dearani, G.K. Danielson.
Surgical management of Ebstein's anomaly in the adult.
Semin Thorac Cardiovasc Surg, 17 (2005), pp. 148-154
[81]
M.L. Brown, J.A. Dearani, G.K. Danielson, F. Cetta, H.M. Connolly, C.A. Warnes, Z. Li, D.O. Hodge, D.J. Driscoll.
Functional status after operation for Ebstein anomaly: the Mayo Clinic experience.
J Am Coll Cardiol, 52 (2008), pp. 460-466
[82]
A.S. Bassett, E.W. Chow, J. Husted, R. Weksberg, O. Caluseriu, G.D. Webb, M.A. Gatzoulis.
Clinical features of 78 adults with 22qll deletion syndrome.
Am J Med Genet A, 138 (2005), pp. 307-313
[83]
V.M. Reddy, J.R. Liddicoat, D.B. McElhinney, M.M. Brook, P. Stanger, F.L. Hanley.
Routine primary repair of tetralogy of Fallot in neonates and infants less than three months of age.
Ann Thorac Surg, 60 (1995), pp. S592-S596
[84]
J.G. Murphy, B.J. Gersh, D.D. Mair, V. Fuster, M.D. McGoon, D.M. Ilstrup, D.C. McGoon, J.W. Kirklin, G.K. Danielson.
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot.
N Engl J Med, 329 (1993), pp. 593-599
[85]
G. Nollert, T. Fischlein, S. Bouterwek, C. Bo’hmer, W. Klinner, B. Reichart.
Longterm survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair.
J Am Coll Cardiol, 30 (1997), pp. 1374-1383
[86]
M.A. Gatzoulis, J.A. Till, J. Somerville, A.N. Redington.
Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.
Circulation, 92 (1995), pp. 231-237
[87]
J.L. Tan, P.A. Davlouros, K.P. McCarthy, M.A. Gatzoulis, S.Y. Ho.
Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilation and aortopathy.
Circulation, 112 (2005), pp. 961-968
[88]
A. Ghai, C. Silversides, L. Harris, G.D. Webb, S.C. Siu, J. Therrien.
Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot.
J Am Coll Cardiol, 40 (2002), pp. 1675-1680
[89]
M.A. Gatzoulis, S. Balaji, S.A. Webber, S.C. Siu, J.S. Hokanson, C. Poile, M. Rosenthal, M. Nakazawa, J.H. Moller, P.C. Gillette, G.D. Webb, A.N. Redington.
Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.
[90]
T. Oosterhof, A. van Straten, H.W. Vliegen, F.J. Meijboom, A.P. van Dijk, A.M. Spijkerboer, B.J. Bouma, A.H. Zwinderman, M.G. Hazekamp, R.A. de, B.J. Mulder.
Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance.
Circulation, 116 (2007), pp. 545-551
[91]
S.V. Babu-Narayan, P.J. Kilner, W. Li, J.C. Moon, O. Goktekin, P.A. Davlouros, M. Khan, S.Y. Ho, D.J. Pennell, M.A. Gatzoulis.
Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome.
Circulation, 113 (2006), pp. 405-413
[92]
S. Cullen, D.S. Celermajer, R.C. Franklin, K.A. Hallidie-Smith, J.E. Deanfield.
Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study.
J Am Coll Cardiol, 23 (1994), pp. 1151-1155
[93]
P. Khairy, M.J. Landzberg, M.A. Gatzoulis, H. Lucron, J. Lambert, F. Marcon, M.E. Alexander, E.P. Walsh.
Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study.
Circulation, 109 (2004), pp. 1994-2000
[94]
P. Khairy, L. Harris, M.J. Landzberg, S. Viswanathan, A. Barlow, M.A. Gatzoulis, S.M. Fernandes, L. Beauchesne, J. Therrien, P. Chetaille, E. Gordon, I. Vonder Muhll, F. Cecchin.
Implantable cardioverter-defibrillators in tetralogy of Fallot.
Circulation, 117 (2008), pp. 363-370
[95]
K. Bull, J. Somerville, E. Ty, D. Spiegelhalter.
Presentation and attrition in complex pulmonary atresia.
J Am Coll Cardiol, 25 (1995), pp. 491-499
[96]
H. Leonard, G. Derrick, J. O'Sullivan, C. Wren.
Natural and unnatural history of pulmonary atresia.
Heart, 84 (2000), pp. 499-503
[97]
K.S. Murthy, S.G. Rao, S.K. Naik, R. Coelho, U.S. Krishnan, K.M. Cherian.
Evolving surgical management for ventricular septal defect, pulmonary atresia, and major aortopulmonary collateral arteries.
Ann Thorac Surg, 67 (1999), pp. 760-764
[98]
V.M. Reddy, D.B. McElhinney, Z. Amin, P. Moore, A.J. Parry, D.F. Teitel, F.L. Hanley.
Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients.
Circulation, 101 (2000), pp. 1826-1832
[99]
E. Belli, L. Mace, M. Ly, P. Dervanian, E. Pineau, R. Roussin, E. Lebret, A. Serraf.
Surgical management of pulmonary atresia with ventricular septal defect in late adolescence and adulthood.
Eur J Cardiothorac Surg, 31 (2007), pp. 236-241
[100]
J.M. Cho, F.J. Puga, G.K. Danielson, J.A. Dearani, D.D. Mair, D.J. Hagler, P.R. Julsrud, D.M. Ilstrup.
Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries.
J Thorac Cardiovasc Surg, 124 (2002), pp. 70-81
[101]
J.A. Dearani, G.K. Danielson, F.J. Puga, H.V. Schaff, C.W. Warnes, D.J. Driscoll, C.D. Schleck, D.M. Ilstrup.
Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits.
Ann Thorac Surg, 75 (2003), pp. 399-410
[102]
A.J. Marelli, J.K. Perloff, J.S. Child, H. Laks.
Pulmonary atresia with ventricular septal defect in adults.
Circulation, 89 (1994), pp. 243-251
[103]
A.N. Redington, J. Somerville.
Stenting of aortopulmonary collaterals in complex pulmonary atresia.
Circulation, 94 (1996), pp. 2479-2484
[104]
Hechter SJ, Webb G, Fredriksen PM, Benson L, Merchant N, Freeman M, Veldtman G, Warsi MA, Siu S, Liu P. Cardiopulmonary exercise performance in adult survivors of the Mustard procedure. Cardiol Young 2001;ll:407-414.
[105]
P. Khairy, M.J. Landzberg, J. Lambert, C.P. O’Donnell.
Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures.
Cardiol Young, 14 (2004), pp. 284-292
[106]
S. Piran, G. Veldtman, S. Siu, G.D. Webb, P.P. Liu.
Heart failure and ventricular dysfunction in patients with single or systemic right ventricles.
Circulation, 105 (2002), pp. 1189-1194
[107]
J.W. Roos-Hesselink, F.J. Meijboom, S.E. Spitaels, R. van Domburg, E.H. van Rijen, E.M. Utens, J. McGhie, E. Bos, A.J. Bogers, M.L. Simoons.
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years).
Eur Heart J, 25 (2004), pp. 1264-1270
[108]
C.A. Warnes.
Transposition of the great arteries.
Circulation, 114 (2006), pp. 2699-2709
[109]
M. Gelatt, R.M. Hamilton, B.W. McCrindle, M. Connelly, A. Davis, L. Harris, R.M. Gow, W.G. Williams, G.A. Trusler, R.M. Freedom.
Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience.
J Am Coll Cardiol, 29 (1997), pp. 194-201
[110]
R. Lange, J. Horer, M. Kostolny, J. Cleuziou, M. Vogt, R. Busch, K. Holper, H. Meisner, J. Hess, C. Schreiber.
Presence of a ventricular septal defect and the Mustard operation are risk factors for late mortality after the atrial switch operation: thirty years of follow-up in 417 patients at a single center.
Circulation, 114 (2006), pp. 1905-1913
[111]
L. Dos, L. Teruel, I.J. Ferreira, J. Rodriguez-Larrea, L. Miro, J. Girona, D.C. Albert, Gon, A. ^alves, M. Murtra, J. Casaldaliga.
Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries.
Heart, 91 (2005), pp. 652-656
[112]
G. Agnoletti, P. Ou, D.S. Celermajer, Y. Boudjemline, D. Marini, D. Bonnet, Y. Aggoun.
Acute angulation of the aortic arch predisposes a patient to ascending aortic dilation and aortic regurgitation late after the arterial switch operation for transposition of the great arteries.
J Thorac Cardiovasc Surg, 135 (2008), pp. 568-572
[113]
M.L. Schwartz, K. Gauvreau, P. del Nido, J.E. Mayer, S.D. Colan.
Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation.
Circulation, 110 (2004), pp. II128-II132
[114]
J. Therrien, Y. Provost, J. Harrison, M. Connelly, H. Kaemmerer, G.D. Webb.
Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study.
Int J Cardiol, 129 (2008), pp. 187-192
[115]
G.F. Van Hare, M.D. Lesh, B.A. Ross, J.C. Perry, P.C. Dorostkar.
Mapping and radiofrequency ablation of intraatrial reentrant tachycardia after the Senning or Mustard procedure for transposition of the great arteries.
Am J Cardiol, 77 (1996), pp. 985-991
[116]
P. Khairy, L. Harris, M.J. Landzberg, S.M. Fernandes, A. Barlow, L.A. Mercier, S. Viswanathan, P. Chetaille, E. Gordon, A. Dore, F. Cecchin.
Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study.
Circ Arrhythm Electrophysiol, l (2008), pp. 250-257
[117]
M. Schwerzmann, O. Salehian, L. Harris, S.C. Siu, W.G. Williams, G.D. Webb, J.M. Colman, A. Redington, C.K. Silversides.
Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries.
Eur Heart J, 30 (2009), pp. 1873-1879
[118]
J. Losay, A. Touchot, A. Capderou, J.D. Piot, E. Belli, C. Planche, A. Serraf.
Aortic valve regurgitation after arterial switch operation for transposition of the great arteries: incidence, risk factors, and outcome.
J Am Coll Cardiol, 47 (2006), pp. 2057-2062
[119]
A. Guedes, L.A. Mercier, L. Leduc, L. Berube, F. Marcotte, A. Dore.
Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries.
J Am Coll Cardiol, 44 (2004), pp. 433-437
[120]
W. Drenthen, P.G. Pieper, M. Ploeg, A.A. Voors, J.W. Roos-Hesselink, B.J. Mulder, H.W. Vliegen, K.M. Sollie, T. Ebels, D.J. van Veldhuisen.
Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries.
Eur Heart J, 26 (2005), pp. 2588-2595
[121]
L.M. Beauchesne, C.A. Warnes, H.M. Connolly, N.M. Ammash, A.J. Tajik, G.K. Danielson.
Outcome of the unoperated adult who presents with congenially corrected transposition of the great arteries.
J Am Coll Cardiol, 40 (2002), pp. 285-290
[122]
M.S. Connelly, P.P. Liu, W.G. Williams, G.D. Webb, P. Robertson, P.R. McLaughlin.
Congenially corrected transposition of the great arteries in the adult: functional status and complications.
J Am Coll Cardiol, 27 (1996), pp. 1238-1243
[123]
A. Giardini, L. Lovato, A. Donti, R. Formigari, G. Oppido, G. Gargiulo, F.M. Picchio, R. Fattori.
Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenially corrected transposition of the great arteries.
Am J Cardiol, 98 (2006), pp. 1277-1282
[124]
A. Dodge-Khatami, I.I. Tulevski, G.B. Bennink, J.F. Hitchcock, B.A. de Mol, E.E. van der Wall, B.J. Mulder.
Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally corrected transposition using MRI dobutamine stress testing.
Ann Thorac Surg, 73 (2002), pp. 1759-1764
[125]
A.A. Alghamdi, B.W. McCrindle, G.S. Van Arsdell.
Physiologic versus anatomic repair of congenitally corrected transposition of the great arteries: meta-analysis of individual patient data.
Ann Thorac Surg, 81 (2006), pp. 1529-1535
[126]
F.A. Mitropoulos, M. Kanakis, A.P. Vlachos, P. Lathridou, G. Tsaoussis, G. Georgiou, J.A. Goudevenos.
Congenitally corrected transposition of the great arteries: surgical repair in adulthood.
Ann Thorac Surg, 83 (2007), pp. 672-674
[127]
T. Shin’oka, H. Kurosawa, Y. Imai, M. Aoki, M. Ishiyama, T. Sakamoto, S. Miyamoto, K. Hobo, Y. Ichihara.
Outcomes of definitive surgical repair for congenitally corrected transposition of the great arteries or double outlet right ventricle with discordant atrioventricular connections: risk analyses in 189 patients.
J Thorac Cardiovasc Surg, 133 (2007), pp. 1318-1328
[128]
J.A. van Son, G.K. Danielson, J.C. Huhta, C.A. Warnes, W.D. Edwards, H.V. Schaff, F.J. Puga, D.M. Ilstrup.
Late results of systemic atrioventricular valve replacement in corrected transposition.
J Thorac Cardiovasc Surg, 109 (1995), pp. 642-652
[129]
M. Voskuil, M.G. Hazekamp, U. Kroft, W.J. Lubbers, J. Ottenkamp, E.E. van der Wall, K.H. Zwinderman, B.J. Mulder.
Postsurgical course of patients with congenially corrected transposition of the great arteries.
Am J Cardiol, 83 (1999), pp. 558-562
[130]
Poirier NC, Gatzoulis MA, Double-inlet ventricle. In: Gatzoulis MA, Webb GD, Daubeney PE, eds. Diagnosis and management of adult congenital heart disease. London: Churchill Livingstone; 2003. p399-403.
[131]
M.A. Gatzoulis, M.D. Munk, W.G. Williams, G.D. Webb.
Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology.
Heart, 83 (2000), pp. 51-57
[132]
T. Gilljam, B.W. McCrindle, J.F. Smallhorn, W.G. Williams, R.M. Freedom.
Outcomes of left atrial isomerism over a 28-year period at a single institution.
J Am Coll Cardiol, 36 (2000), pp. 908-916
[133]
A. Hashmi, R. Abu-Sulaiman, B.W. McCrindle, J.F. Smallhorn, W.G. Williams, R.M. Freedom.
Management and outcomes of right atrial isomerism: a 26-year experience.
J Am Coll Cardiol, 31 (1998), pp. 1120-1126
[134]
P. Khairy, N. Poirier, L.A. Mercier.
Univentricular heart.
Circulation, 115 (2007), pp. 800-812
[135]
P.S. Ro, J. Rychik, M.S. Cohen, W.T. Mahle, J.J. Rome.
Diagnostic assessment before Fontan operation in patients with bidirectional cavopulmonary anastomosis: are noninvasive methods sufficient?.
J Am Coll Cardiol, 44 (2004), pp. 184-187
[136]
M.R. de Leval, P. Kilner, M. Gewillig, C. Bull.
Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience.
J Thorac Cardiovasc Surg, 96 (1988), pp. 682-695
[137]
S.J. Kim, W.H. Kim, H.G. Lim, J.Y. Lee.
Outcome of 200 patients after an extracardiac Fontan procedure.
J Thorac Cardiovasc Surg, 136 (2008), pp. 108-116
[138]
F. Fontan, J.W. Kirklin, G. Fernandez, F. Costa, D.C. Naftel, F. Tritto, E.H. Blackstone.
Outcome after a ‘perfect’ Fontan operation.
Circulation, 81 (1990), pp. 1520-1536
[139]
P. Khairy, S.M. Fernandes, J.E. Mayer Jr., J.K. Triedman, E.P. Walsh, J.E. Lock, M.J. Landzberg.
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.
[140]
A. Giardini, A. Hager, C. Pace Napoleone, F.M. Picchio.
Natural history of exercise capacity after the Fontan operation: a longitudinal study.
Ann Thorac Surg, 85 (2008), pp. 818-821
[141]
K. Durongpisitkul, C.J. Porter, F. Cetta, K.P. Offord, J.M. Slezak, F.J. Puga, H.V. Schaff, G.K. Danielson, D.J. Driscoll.
Predictors of early- and late-onset supraventricular tachyarrhythmias after Fontan operation.
Circulation, 98 (1998), pp. 1099-1107
[142]
Y. d’Udekem, A.J. Iyengar, A.D. Cochrane, L.E. Grigg, J.M. Ramsay, G.R. Wheaton, D.J. Penny, C.P. Brizard.
The Fontan procedure: contemporary techniques have improved long-term outcomes.
Circulation, 116 (2007), pp. 1157-1164
[143]
L. Mertens, D.J. Hagler, U. Sauer, J. Somerville, M. Gewillig.
Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group.
J Thorac Cardiovasc Surg, 115 (1998), pp. 1063-1073
[144]
Y.F. Cheung, G.W. Chay, C.S. Chiu, L.C. Cheng.
Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.
Int J Cardiol, 102 (2005), pp. 509-513
[145]
D.J. Abrams, M.J. Earley, S.C. Sporton, P.M. Kistler, M.A. Gatzoulis, M.J. Mullen, J.A. Till, S. Cullen, F. Walker, M.D. Lowe, J.E. Deanfield, R.J. Schilling.
Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure.
Circulation, 115 (2007), pp. 1738-1746
[146]
C.B. Huddleston.
The failing Fontan: options for surgical therapy.
Pediatr Cardiol, 28 (2007), pp. 472-476
[147]
C. Mavroudis, B.J. Deal, C.L. Backer, R.D. Stewart, W.H. Franklin, S. Tsao, K.M. Ward, R.A. DeFreitas.
J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. Ill Fontan conversions with arrhythmia surgery: surgical lessons and outcomes.
Ann Thorac Surg, 84 (2007), pp. 1457-1465
[148]
C.A. Caldarone, B.W. McCrindle, G.S. Van Arsdell, J.G. Coles, G. Webb, R.M. Freedom, W.G. McWilliams.
Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits.
J Thorac Cardiovasc Surg, 120 (2000), pp. 1022-1030
[149]
S. Mohammadi, E. Belli, I. Martinovic, L. Houyel, A. Capderou, J. Petit, C. Planche, A. Serraf.
Surgery for right ventricle to pulmonary artery conduit obstruction: risk factors for further reoperation.
Eur J Cardiothorac Surg, 28 (2005), pp. 217-222
[150]
L.F. Peng, D.B. McElhinney, A.W. Nugent, A.J. Powell, A.C. Marshall, E.A. Bacha, J.E. Lock.
Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience.
Circulation, 113 (2006), pp. 2598-2605
[151]
H. Sugiyama, W. Williams, L.N. Benson.
Implantation of endovascular stents for the obstructive right ventricular outflow tract.
Heart, 91 (2005), pp. 1058-1063
[152]
P. Bonhoeffer, Y. Boudjemline, Z. Saliba, J. Merckx, Y. Aggoun, D. Bonnet, P. Acar, J. Le Bidois, D. Sidi, J. Kachaner.
Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.
Lancet, 356 (2000), pp. 1403-1405
[153]
A. Frigiola, V. Tsang, C. Bull, L. Coats, S. Khambadkone, G. Derrick, B. Mist, F. Walker, C. van Doom, P. Bonhoeffer, A.M. Taylor.
Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome?.
Circulation, 118 (2008), pp. S182-S190
[154]
S. Khambadkone, P. Bonhoeffer.
Nonsurgical pulmonary valve replacement: why, when, and how?.
Catheter Cardiovasc Interv, 62 (2004), pp. 401-408
[155]
P. Lurz, L. Coats, S. Khambadkone, J. Nordmeyer, Y. Boudjemline, S. Schievano, V. Muthurangu, T.Y. Lee, G. Parenzan, G. Derrick, S. Cullen, F. Walker, V. Tsang, J. Deanfield, A.M. Taylor, P. Bonhoeffer.
Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome.
Circulation, 117 (2008), pp. 1964-1972
[156]
VongpatanasinW, M.E. Brickner, L.D. Hillis, R.A. Lange.
The Eisenmenger syndrome in adults.
Ann Intern Med, 128 (1998), pp. 745-755
[157]
M.G. Duffels, P.M. Engelfriet, R.M. Berger, R.L. van Loon, E. Hoendermis, J.W. Vriend, E.T. van der Velde, P. Bresser, B.J. Mulder.
Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.
Int J Cardiol, 120 (2007), pp. 198-204
[158]
R.M. Tuder, S.H. Abman, T. Braun, F. Capron, T. Stevens, P.A. Thistlethwaite, S.G. Haworth.
Development and pathology of pulmonary hypertension.
J Am Coll Cardiol, 54 (2009), pp. S3-S9
[159]
E. Oechslin, KiowskiW, R. Schindler, A. Bernheim, B. Julius, H.P. Brunner-La Rocca.
Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
Circulation, 112 (2005), pp. 1106-1112
[160]
G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, R. Souza.
Updated clinical classification of pulmonary hypertension.
J Am Coll Cardiol, 54 (2009), pp. S43-S54
[161]
C.S. Broberg, M. Ujita, S. Prasad, W. Li, M. Rubens, B.E. Bax, S.J. Davidson, B. Bouzas, J.S. Gibbs, J. Burman, M.A. Gatzoulis.
Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity.
J Am Coll Cardiol, 50 (2007), pp. 634-642
[162]
G.P. Diller, K. Dimopoulos, C.S. Broberg, M.G. Kaya, U.S. Naghotra, A. Uebing, C. Harries, O. Goktekin, J.S. Gibbs, M.A. Gatzoulis.
Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study.
Eur Heart J, 27 (2006), pp. 1737-1742
[163]
L. Daliento, J. Somerville, P. Presbitero, L. Menti, S. Brach-Prever, G. Rizzoli, S. Stone.
Eisenmenger syndrome. Factors relating to deterioration and death.
Eur Heart J, 19 (1998), pp. 1845-1855
[164]
N. Galie, M. Beghetti, M.A. Gatzoulis, J. Granton, R.M. Berger, A. Lauer, E. Chiossi, M. Landzberg.
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
[165]
K. Dimopoulos, R. Inuzuka, S. Goletto, G. Giannakoulas, L. Swan, S.J. Wort, M.A. Gatzoulis.
Improved survival amon patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension.
[166]
T.P. Singh, M. Rohit, A. Grover, S. Malhotra, R. Vijayvergiya.
A randomized, placebocontrolled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
[167]
S. Mukhopadhyay, M. Sharma, S. Ramakrishnan, J. Yusuf, M.D. Gupta, N. Bhamri, V. Trehan, S. Tyagi.
Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.
Circulation, 114 (2006), pp. 1807-1810
[168]
S.M. Fernandes, J.W. Newburger, P. Lang, D.D. Pearson, J.A. Feinstein, K. Gauvreau, M.J. Landzberg.
Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology.
Am J Cardiol, 91 (2003), pp. 632-635
[169]
E.B. Rosenzweig, D. Kerstein, R.J. Barst.
Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
Circulation, 99 (1999), pp. 1858-1865
[170]
G. Simonneau, R.J. Barst, N. Galie, R. Naeije, S. Rich, R.C. Bourge, A. Keogh, R. Oudiz, A. Frost, S.D. Blackburn, J.W. Crow, L.J. Rubin.
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
Am J Respir Crit Care Med, 165 (2002), pp. 800-804
[171]
Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 2004; 97 (Suppl l):109-115.
[172]
J.K. Perloff, M.H. Rosove, J.S. Child, G.B. Wright.
Adults with cyanotic congenital heart disease: hematologic management.
Ann Intern Med, 109 (1988), pp. 406-413
[173]
C.S. Broberg, B.E. Bax, D.O. Okonko, M.W. Rampling, S. Bayne, C. Harries, S.J. Davidson, A. Uebing, A.A. Khan, S. Thein, J.S. Gibbs, J. Burman, M.A. Gatzoulis.
Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
J Am Coll Cardiol, 48 (2006), pp. 356-365
[174]
J.K. Perloff.
Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements renal function, and urate metabolism.
Cardiol Clin, 11 (1993), pp. 689-699
[175]
P. Engelfriet, E. Boersma, E. Oechslin, J. Tijssen, M.A. Gatzoulis, U. Thilen, H. Kaemmerer, P. Moons, F. Meijboom, J. Popelova, V. Laforest, R. Hirsch, L. Daliento, E. Thaulow, B. Mulder.
The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease.
Eur Heart J, 26 (2005), pp. 2325-2333
[176]
H. Sakazaki, K. Niwa, S. Echigo, T. Akagi, M. Nakazawa.
Predictive factors for longterm prognosis in adults with cyanotic congenital heart disease—Japanese multicenter study.
Int J Cardiol, 120 (2007), pp. 72-78
[177]
W.J. Cantor, D.A. Harrison, J.S. Moussadji, M.S. Connelly, G.D. Webb, P. Liu, P.R. McLaughlin, S.C. Siu.
Determinants of survival and length of survival in adults with Eisenmenger syndrome.
Am J Cardiol, 84 (1999), pp. 677-681
[178]
K. Niwa, J.K. Perloff, S. Kaplan, J.S. Child, P.D. Miner.
Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart.
J Am Coll Cardiol, 34 (1999), pp. 223-232
[179]
J.K. Perloff, E.M. Hart, S.M. Greaves, P.D. Miner, J.S. Child.
Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension.
Am J Cardiol, 92 (2003), pp. 182-187
[180]
C.K. Silversides, J.T. Granton, E. Konen, M.A. Hart, G.D. Webb, J. Therrien.
Pulmonary thrombosis in adults with Eisenmenger syndrome.
J Am Coll Cardiol, 42 (2003), pp. 1982-1987
[181]
J.K. Perloff, A.J. Marelli, P.D. Miner.
Risk of stroke in adults with cyanotic congenital heart disease.
Circulation, 87 (1993), pp. 1954-1959
[182]
N. Ammash, C.A. Warnes.
Cerebrovascular events in adult patients with cyanotic congenital heart disease.
J Am Coll Cardiol, 28 (1996), pp. 768-772
[183]
C.S. Broberg, A. Uebing, L. Cuomo, S.L. Thein, M.G. Papadopoulos, M.A. Gatzoulis.
Adult patients with Eisenmenger syndrome report flying safely on commercial airlines.
Heart, 93 (2007), pp. 1599-1603
[184]
E. Harinck, P.A. Hutter, T.M. Hoorntje, M. Simons, A.A. Benatar, J.C. Fischer, B.D. de, E.J. Meijboom.
Air travel and adults with cyanotic congenital heart disease.
Circulation, 93 (1996), pp. 272-276

0 conteudo destas Recomendacoes da European Society of Cardiology (ESC) foi publicado apenas para uso pessoal e educativo. Nao esta autorizado o seu uso comercial. Nenhuma parte das Recomendacoes da ESC pode sertraduzida ou reproduzida sob qualquer forma sem a autorizacao por escrito da ESC. A autorizacao pode ser obtida mediante apresentacao de um pedido por escrito dirigido a Oxford University Press, ao editor do European Heart Journal e ao responsavel por dar essa autorizacao em nome da ESC. Renuncia de responsabilidade. As Recomendacoes da ESC expressam a opiniao da ESC e foram elaboradas apos cuidadosa consideracao das evidencias disponiveis a data da sua redaccao. Os profissionais de saude sao encorajados a te-las em consideracao no exercicio da sua avaliacao clinica. No entanto, as orientacoes nao se devem sobrepor a responsabilidade individual dos profissionais de saude de tomarem as decisoes ajustadas com base nas circunstancias especificas dos doentes de forma individualizada, de mutuo acordo com cada doente e, se for caso disso e exigido, com o representante ou encarregado do doente. Cabe igualmente ao profissional de saude verificar as regras e regulamentos aplicaveis aos medicamentos e dispositivos medicos a data da prescricao do tratamento. © The European Society of Cardiology 2010. Todos os direitos reservados. Qualquer pedido de autorizacao deve ser dirigido por e-mail para o seguinte endereco: journals.permissions@oxfordjournals.org

Idiomas
Revista Portuguesa de Cardiologia

Receba a nossa Newsletter

Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.